NO20054002L - Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom - Google Patents
Behandlingsmiddel for diar±-predominant irritabel tarmsyndromInfo
- Publication number
- NO20054002L NO20054002L NO20054002A NO20054002A NO20054002L NO 20054002 L NO20054002 L NO 20054002L NO 20054002 A NO20054002 A NO 20054002A NO 20054002 A NO20054002 A NO 20054002A NO 20054002 L NO20054002 L NO 20054002L
- Authority
- NO
- Norway
- Prior art keywords
- diarrhea
- treatment
- bowel syndrome
- irritable bowel
- predominantly
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title 1
- 208000002551 irritable bowel syndrome Diseases 0.000 title 1
- NTHPAPBPFQJABD-LLVKDONJSA-N ramosetron Chemical compound C12=CC=CC=C2N(C)C=C1C(=O)[C@H]1CC(NC=N2)=C2CC1 NTHPAPBPFQJABD-LLVKDONJSA-N 0.000 abstract 2
- 229950001588 ramosetron Drugs 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001142 anti-diarrhea Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2004/000896 WO2004066998A1 (fr) | 2003-01-31 | 2004-01-30 | Composition medicinale solide, stable, d'administration par voie orale |
| PCT/JP2004/006657 WO2005073220A1 (fr) | 2004-01-30 | 2004-05-12 | Remede contre le syndrome du colon irritable avec diarrhee |
| PCT/JP2005/001549 WO2005072730A1 (fr) | 2004-01-30 | 2005-01-27 | Agent therapeutique pour le syndrome de l’intestin irritable de type diarrhoe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054002D0 NO20054002D0 (no) | 2005-08-29 |
| NO20054002L true NO20054002L (no) | 2005-10-26 |
Family
ID=34829390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054002A NO20054002L (no) | 2004-01-30 | 2005-08-29 | Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom |
Country Status (8)
| Country | Link |
|---|---|
| AU (1) | AU2005209112B2 (fr) |
| BR (1) | BRPI0503488A (fr) |
| CA (1) | CA2516433C (fr) |
| MX (1) | MXPA05009025A (fr) |
| NO (1) | NO20054002L (fr) |
| NZ (1) | NZ541656A (fr) |
| RU (1) | RU2314808C2 (fr) |
| WO (1) | WO2005072730A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE144511T1 (de) * | 1989-02-02 | 1996-11-15 | Yamanouchi Pharma Co Ltd | Tetrahydrobenzimidazol-derivate |
| GB9721139D0 (en) * | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
| US6852725B1 (en) * | 1998-06-12 | 2005-02-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S. A. S. | Imidazolyl derivatives |
| AR028970A1 (es) * | 2000-07-26 | 2003-05-28 | Solvay Pharm Gmbh | USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE |
-
2005
- 2005-01-27 NZ NZ541656A patent/NZ541656A/en not_active IP Right Cessation
- 2005-01-27 RU RU2005127333/15A patent/RU2314808C2/ru not_active IP Right Cessation
- 2005-01-27 WO PCT/JP2005/001549 patent/WO2005072730A1/fr not_active Ceased
- 2005-01-27 BR BRPI0503488-4A patent/BRPI0503488A/pt not_active IP Right Cessation
- 2005-01-27 MX MXPA05009025A patent/MXPA05009025A/es active IP Right Grant
- 2005-01-27 CA CA002516433A patent/CA2516433C/fr not_active Expired - Fee Related
- 2005-01-27 AU AU2005209112A patent/AU2005209112B2/en not_active Ceased
- 2005-08-29 NO NO20054002A patent/NO20054002L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005072730A1 (fr) | 2005-08-11 |
| BRPI0503488A (pt) | 2006-03-07 |
| RU2005127333A (ru) | 2006-07-10 |
| RU2314808C2 (ru) | 2008-01-20 |
| MXPA05009025A (es) | 2006-04-27 |
| NO20054002D0 (no) | 2005-08-29 |
| CA2516433A1 (fr) | 2005-08-11 |
| AU2005209112A1 (en) | 2005-08-11 |
| AU2005209112B2 (en) | 2007-07-05 |
| NZ541656A (en) | 2008-05-30 |
| CA2516433C (fr) | 2009-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2248519A3 (fr) | Formes galéniques de film non mucoadhésifs | |
| FI3782612T3 (fi) | Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi | |
| ES2916649T1 (es) | Composiciones y usos para el tratamiento de la esclerosis múltiple | |
| NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
| NO20062513L (no) | Sammensetninger og doseringsformer for forsterket absorpsjon av metformin | |
| MX2025001619A (es) | Inhibidor de pde4b y uso del mismo | |
| CY1124914T1 (el) | Στερεες φαρμακευτικες συνθεσεις που περιεχουν αναστολεα ιντεγκρασης | |
| MY148108A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| ECSP077387A (es) | Composiciones que contienen piperacilina, tazobactam y un ácido aminocarboxílico en un diluyente de lactato de sodio | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| WO2021168483A3 (fr) | Traitement d'infections à coronavirus humain à l'aide d'inhibiteurs de traitement de glycoprotéine alpha-glucosidase | |
| IL196425A0 (en) | Pharmaceutical compositions containing ibuprofen and famotidine | |
| NO20080244L (no) | Doseringsstyring for prasugrel | |
| AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| ES2175663T3 (es) | Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis. | |
| CL2024003616A1 (es) | Composición farmacéutica oral y uso para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| NO20054002L (no) | Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom | |
| RU2003104798A (ru) | Содержащие циланзетрон лекарственные средства для лечения не страдающих запорами пациентов мужского пола с синдромом раздраженного кишечника (срк) | |
| AR066667A1 (es) | Composiciones farmaceuticas que comrenden la combinacion de un agente derivado hidrogenado de lipstatina y un agente inhibidor de hmg coa reductasa | |
| SG146631A1 (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
| NO20044900L (no) | Progestagene doseringsenheter | |
| RU2023121182A (ru) | Применение 1-(2-(1н-имидазол-4-ил)этил)пиперидин-2,6-диона для лечения кашля, вызванного вирусными инфекциями | |
| EA200500957A1 (ru) | Применение l-допа, его производных и лекарственных средств, содержащих эти соединения, для профилактики психотических заболеваний | |
| MX2024001230A (es) | Anticoncepcion oral con progestageno solo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |